A fter decades of delay, if compared to other medical emergencies like myocardial infarction, knowledge about stroke finally achieved a grade that allows intervention to change its natural history. That has been a long road.
1
. The question had a turning point in 2015, when new randomized clinical trials showed that intra-arterial thrombolysis alone or in combination with IV t-PA was superior to IV t-PA alone, in a selected population of patients harbouring large vessel occlusions 2 . Additionally, these trials revealed a set of indicators of performance, which improvement is associated with better outcomes, like frequency of complete recanalization and time needed to achieve it.
Part of the effort to improve outcomes by improving the IAT indicators is reported in the present issue
